Streetbeat News

Price Targets

IPWR

Benchmark analyst David Williams has reiterated a 'Buy' rating on Ideal Power (NASDAQ:IPWR) and maintained a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 3:37 pm

TGTX

B. Riley Securities analyst Mayank Mamtani maintains a Buy rating on TG Therapeutics (NASDAQ:TGTX) but has lowered the price target from $32 to $24.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 3:27 pm

AA

B. Riley Securities has maintained a Neutral rating on Alcoa (NYSE:AA) and lowered the price target from $34 to $26.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 3:19 pm

ASM

Roth MKM analyst Joe Reagor maintains a 'Buy' rating on Avino Silver & Gold Mines (AMEX:ASM) and raises the price target from $1.6 to $1.8.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 3:08 pm

EFX

Wells Fargo analyst Seth Weber has maintained an Equal-Weight rating on Equifax (NYSE:EFX) and lowered the price target from $215 to $200.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 2:55 pm

WOLF

Wells Fargo analyst Gary Mobley has maintained an Overweight rating on Wolfspeed (NYSE:WOLF) but lowered the price target from $60 to $50.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 2:54 pm

CCI

Wells Fargo analyst Eric Luebchow has maintained an Underweight rating on Crown Castle (NYSE:CCI) and lowered the price target from $100 to $90.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 2:53 pm

ISRG

Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on Intuitive Surgical (NASDAQ:ISRG) but lowered the price target from $386 to $363.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 2:51 pm

UHS

Wells Fargo analyst Stephen Baxter has maintained an Equal-Weight rating on Universal Health Services (UHS) but lowered the price target from $153 to $139.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 2:50 pm

THC

Wells Fargo analyst Stephen Baxter has maintained an Overweight rating on Tenet Healthcare (NYSE:THC) but lowered the price target from $83 to $71.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 2:50 pm